This year, the first week of October, from October 2nd to 4th, will be dedicated to the Fourth Congress of Geneticists in Bosnia and Herzegovina with international participation. For the first time, this significant event will be held in Banja Luka – a city that is a perfect blend of history, nature, and adventure. With the beautiful Vrbas River, rich cultural heritage, and vibrant urban spirit, this city offers something for everyone. The congress will take place in the modern facilities of Hotel Bosna, providing an ideal environment for scientific exchange and networking.
Join us for the truly global forum that will bring together the international genetics community to share ideas and the latest research. The Congress will cover the breadth of fundamental discoveries in genetics and genomics, the latest advances in technologies, and important and topical applications in areas such as health, agriculture and the conversation of species and the environment.
STUDENT PARTICIPATION – PASSIVE ATTENDANCE
Students who wish to attend the congress lectures as passive participants must register through the official registration system. The registration fee for passive student participants is free of charge and includes access to lectures only. Please note that promotional materials, coffee breaks, lunch, and social events are not included.
IMPORTANT NOTE:
All students, both active and passive participants, are required to submit valid proof of student status within two weeks of registration to the following email address: genubih.congress@gmail.com
MOLECULAR AND GENETIC TOOLS IN LIFESCIENCES – AN OVERVIEW
PATHWAYS TO GENOMIC MEDICINE IN HEALTHCARE
FROM DISCOVERY TO APPLICATION
ASSESSMENT OF ACUTE EXPOSURE TO ENERGY DRINKS AND THEIR MAJOR COMPOUNDS (CAFFEINE AND TAURINE) ON FUNCTIONAL CHARACTERISTICS OF NT2-DERIVED NEURONS AND ASTROCYTES
BODY COMPOSITION IN PEDIATRIC PATIENTS WITH MARFAN SYNDROME
PROFESSIONAL GUIDELINES FOR THE IMPROVEMENT OF HIGHER EDUCATION PROGRAMS IN THE FIELD OF BIOTECHNOLOGY IN BOSNIA AND HERZEGOVINA
CeGaT – COMPREHENSIVE GENETIC SOLUTIONS
FROM EXPOSURE TO EFFECT: GENOTOXICITY PROFILING OF INDOOR AIR POLLUTANTS USING ADVANCED IN VITRO 3D LIVER CELL MODELS
IMMUNOTOXIC EFFECTS OF NANOPARTICLES: AN EVALUATION OF INFLUENCING FACTORS
UNRAVELING THE GENETIC PUZZLE OF EARLY PREGNANCY LOSS: FROM CHROMOSOMES TO RARE MONOGENIC DISORDERS
NEWBORN SCREENING FOR SMA: HOW TIMELY DIAGNOSIS CHANGES LIVES
FROM THE LOCAL DIVERSITY OF TICK-BORNE PATHOGENS IN QUESTING TICKS TOWARDS TAILOR MADE APPROACHES IN MANAGEMENT OF TICK-BORNE DISEASES – PRELIMINARY RESULTS OF TALKTOTICK PROJECT
MICROSCOPIC THREATS, MACROSCOPIC IMPACT: A DECADE OF TICK RESEARCH AND PUBLIC HEALTH IMPLICATIONS
THE PAST AND FUTURE OF FORESTRY BASED ON BİOTECHNOLOGY
EUROGENTEST INITIATIVES AND EVIDENCE FOR THE ROLE OF EXTERNAL QUALITY ASSESSMENT IN DRIVING LABORATORY IMPROVEMENT
CYTOTOXIC AND GENOTOXIC EFFECTS OF BERBERINE-GEMCITABINE COMBINATION IN A549 HUMAN LUNG CANCER CELLS
COMPREHENSIVE ASSESSMENT OF DNA DAMAGE, CYTOTOXICITY, APOPTOSIS, AND OXIDATIVE STRESS INDUCED BY TURKISH ROSEHIP (Rosa canina L.) EXTRACTS IN GLIOBLASTOMA AND MELANOMA CELLS
A NEW INSIGHT INTO THE IMPACT OF THE CES1 RS2244613 VARIANT ON CLOPIDOGREL THERAPY RESPONSE: POTENTIAL PROTECTIVE ROLE
DO GENES DRIVE KIDNEY STONES? EVIDENCE FROM SLOVENIAN PATIENTS AND POPULATION STUDIES
PHARMACOGENOMICS OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN IN SERBIA
PHARMACOGENETICS IN ACUTE ISCHEMIC STROKE: CURRENT PERSPECTIVES AND FUTURE DIRECTIONS
PHARMACOGENETIC APPROACHES IN THE MANAGEMENT OF RHEUMATIC DISEASES: CURRENT TRENDS AND FUTURE CHALLENGES
ALTERATION OF THE EXPRESSION OF A SET OF PROTEINS THAT DEFINES A "HIGH-RISK" PROGNOSTIC PROFILE IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER
MULTI-OMICS AND DOCKING STRATEGIES REVEAL CANDIDATE PATHWAYS DRIVING VASCULAR INVASION IN RECTAL CARCINOMA
APPLICATION OF MODERN METHODOLOGY IN GENETIC ANALYSES FOR THE MASS IDENTIFICATION OF MISSING PERSONS IN BOSNIA AND HERZEGOVINA
AUTOPHAGY AS A POTENTIAL MODULATOR OF CELLULAR LONGEVITY
